Susan Hasty, Publisher
Table of Contents . . . November 13th, 1995Non-Subscriber - Summaries Only
Cancer Gene Therapy - In Vivo Experiments Compare Two Genetically Engineered Therapies
Conference Coverage (ICAAC) - The Wave of the Future: Nucleic Acid Vaccines
Breast Cancer (Prognosis) - Understanding of the p53 Gene's Role in Cancer
Breast Cancer (Risk) - Food Dyes May Raise Breast Cancer Risk, Scientists Find
Breast Cancer (Therapy) - Combination Therapy Demonstrates Significant Activity
Colorectal Cancer (Screening) - Test Detects Cancer Recurrences in the Liver Early and Accurately
Colorectal Cancer (Therapy) - Results of Irinotecan Reported on at Conference
Head and Neck Cancer (Therapy) - Results of Docetaxol Reported on at Conference
Industry News (Clinical Trials) - Company Reports on Lymphoma Trial Combining IDEC-C2B8 with Chemotherapy
Industry News (Screening) - Bladder Cancer Test Scheduled for Review by Immunology Devices Panel
Industry News (Testing) - FDA Advisory Panel Announced
Industry News (Therapy) - European Trial Results Show Survival Improvement in Brain Cancer
Industry News (Therapy) - Marine-Based Compounds Hold Promise To Treat Breast/Other Cancers
Industry News (Therapy) - New Firm Focusing on Antiviral, Anticancer Therapies
International (Europe) - Cancer Patients Need To Be Better Informed
Prostate Cancer (Screening) - Better Detection Responsible for Rise in Cancer Rates
Prevention (HIV - Cancer) - "Community-Based Public Health Models for Prevention of Cancer and HIV/AIDS."
Therapy (Gene Transfer) - "Gene Therapy in a Experimental Model of Hepatocellular Carcinoma (HCC)."
Antisense Technology - "Combination Anti-Gene Therapy Targeting c-myc and p53 in Ovarian Cancer Cell Lines."
Prostate Cancer - "Characterization of a Prostate Carcinoma Mucin-Like Antigen (PMA)."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.